Provider review
Lemonaid Health tirzepatide review
Lemonaid Health tirzepatide: dated cost records, plan details and questions to ask before enrolling. Public-source editorial, without a test purchase or clinical rating.
Updated 2026-09-18 · Public-source editorial · See dated evidence below
Lemonaid has been in telehealth far longer than most of this field, and its multi-month plans cut the medication price hard — but a $49 monthly membership is charged on top of every tier.
Month-to-month, compounded tirzepatide is $299 plus the $49 membership, so about $348. Commit to six months and the medication drops to $229, taking the working figure to roughly $278. The advertised "from $129" is a programme floor and does not describe the injection.
Recorded costs and what to confirm
| Comparison step | Tirzepatide at Lemonaid Health |
|---|---|
| Earlier figures | Dated cost record |
| Treatment | Name the product, route, prescribed amount and supply period |
| First payment | Itemize medicine, care, tests, supplies and delivery |
| Renewal | Give the next charge, its date and the supply it covers |
| Change or exit | Explain remaining charges and any refund before payment |
Month-to-month medication is $299 plus the $49 membership. Committing to six months brings the medication to $229, so about $278 all in.
Between roughly $3,336 and $4,176 a year depending on commitment length. Mid-table, and the membership is what keeps it there.
How Lemonaid Health works
Long-running telehealth platform offering compounded GLP-1s on monthly and multi-month plans, with a separate monthly membership.
An established platform with a long operating history, which counts for something when smaller sellers are appearing and disappearing. A microdose tier is offered at $199, and that is a different treatment from full-dose therapy rather than a cheaper version of it.
The earlier source record
- GLP-1 programmes advertised from $129/month.
- Membership is $49/month after the first month.
- Compounded tirzepatide: $299/month monthly, $249/month on a 3-month plan, $229/month on a 6-month plan.
- A compounded tirzepatide microdose tier is listed at $199/month.
- Medication is billed separately from the membership.
The underlying record is dated 2026-09-18. Its amounts, plan details and service descriptions are historical. Confirm the exact product, billing interval, included services and renewal terms before using a figure as a budget.
Where it is strong
- Multi-month plans cut the medication price substantially.
- An established platform with a long operating history in telehealth.
- Microdose tier available for people who want a gentler option.
Where it falls short
- The $49 monthly membership is charged on top of every medication tier.
- The advertised "from $129" does not describe the injection price.
The thing most people miss
Add $49/month to every price you are quoted. The advertised $129 is a programme floor, not the injection cost.
How it scored
The historical rubric gives Lemonaid Health 3.5 out of 5. Display position 17 of 23 also reflects commercial placements; it is not a clinical quality rank. These scores have not been independently revalidated. See how we rate.
| What we weigh | Weight | Score |
|---|---|---|
| True monthly cost | 30% | 3.4 / 5 |
| Price honesty | 20% | 3.2 / 5 |
| Clinical support | 20% | 3.8 / 5 |
| Pharmacy sourcing | 15% | 3.6 / 5 |
| Cancelling | 15% | 3.6 / 5 |
Who it suits
Sensible if you want an established operator and will commit to six months. Poor value month-to-month, where the fee does the most damage.
Our verdict
Solid and unexciting. Add $49 to every figure you are quoted, then compare — the six-month plan is the only tier that competes.
How it compares on tirzepatide
| # | Provider | Cost record | Compare a new quote | Historical score |
|---|---|---|---|---|
| 1 | Coreage Rx Featured | Dated cost record | Product, supply, fees and renewal | 4.5 |
| 2 | SuperHealthy Rx | Dated cost record | Product, supply, fees and renewal | Not scored |
| 3 | Likeness Rx | Dated cost record | Product, supply, fees and renewal | Not scored |
| 4 | Trimi | Dated cost record | Product, supply, fees and renewal | 4.6 |
| 5 | PlexusDx | Dated cost record | Product, supply, fees and renewal | 4.4 |
| 6 | Ozari Health | Dated cost record | Product, supply, fees and renewal | 4.4 |
| 7 | Fifty 410 | Dated cost record | Product, supply, fees and renewal | 4.2 |
| 8 | Ivím Health | Dated cost record | Product, supply, fees and renewal | 4 |
| 9 | Mochi Health | Dated cost record | Product, supply, fees and renewal | 3.6 |
| 10 | Coby Health | Dated cost record | Product, supply, fees and renewal | 3.6 |
| 11 | Hims & Hers | Dated cost record | Product, supply, fees and renewal | 3.5 |
| 12 | Ro | Dated cost record | Product, supply, fees and renewal | 3.5 |
The full reasoning behind this order is in our best tirzepatide providers guide.
Read next
- Coreage Rx tirzepatide review
Coreage Rx tirzepatide: dated cost records, plan details and questions to ask before enrolling. Public-source editorial, without a test purchase or clinical rating.
- Likeness Rx semaglutide review
Likeness Rx semaglutide: dated cost records, plan details and questions to ask before enrolling. Public-source editorial, without a test purchase or clinical rating.
- Trimi tirzepatide review
Trimi tirzepatide: dated cost records, plan details and questions to ask before enrolling. Public-source editorial, without a test purchase or clinical rating.
- The best tirzepatide providers in 2026
23 historical provider records, with cost-component questions, clinical evidence limits and commercial placements explained.
- Lemonaid Health semaglutide review
Lemonaid Health semaglutide: dated cost records, plan details and questions to ask before enrolling. Public-source editorial, without a test purchase or clinical rating.
- How to Compare GLP-1 Costs: Fees, Refills and Renewal
Separate medication, care fees, supply duration, prepayment and renewal when comparing a GLP-1 quote.
Coreage Rx pays us a commission on sign-ups through our links. Commercial placements affect display order; the tables are not clinical recommendations. How we rate · Disclosure
